Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 5.1 EX-5.1
- 8.1 EX-8.1
- 8.2 EX-8.2
- 10.81 EX-10.81
- 10.82 EX-10.82
- 10.83 EX-10.83
- 10.84 EX-10.84
- 10.85 EX-10.85
- 23.1 EX-23.1
- 23.2 EX-23.2
- 23.3 EX-23.3
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
- 99.5 EX-99.5
- 99.6 EX-99.6
- 99.7 EX-99.7
- 99.8 EX-99.8
ANIP similar filings
- 26 Apr 13 Registration of securities issued in business combination transactions
- 18 Jan 13 Registration of securities issued in business combination transactions (amended)
- 11 Dec 12 Registration of securities issued in business combination transactions
- 19 Aug 09 Registration of securities issued in business combination transactions (amended)
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement of BioSante Pharmaceuticals, Inc. on Form S-4 to be filed on or about April 25, 2013 of our report dated April 25, 2013, on our audit of ANIP Acquisition Company (d/b/a ANI Pharmaceuticals, Inc.) financial statements as of December 31, 2012 and for the year ended December 31, 2012. We also consent to the reference to our firm under the caption “Experts” in the Registration Statement on Form S-4.
/s/ EISNERAMPER LLP |
|
|
|
New York, New York |
|
April 25, 2013 |
|